verified SJR 1,072 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

Expert Review of Clinical Pharmacology

Expert Review of Clinical Pharmacology is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology (medical) with an H index of 67. It has a price of 2480 €. It has an SJR impact factor of 1,072 and it has a best quartile of Q1. It has an SJR impact factor of 1,072.

ISSN: 1751-2433

Publisher: Taylor and Francis Ltd.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,072 Q1

H-index 67

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.480 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,072

H-index

Docs (year)

110

Docs 3y

370

Total refs

7790

Cites 3y

1341

Citable 3y

339

Cites/Doc 2y

3.02

Ref/Doc

70.82

Immediate OA

2480 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

British Pharmacology Society Winter Meeting: focus on neuropharmacology

Why highly effective drugs are not enough: the need for an affordable solution to eliminating HCV

Detection of hydrogen sulfide in biological samples: current and future

Design and analysis considerations for thorough QT studies employing conventional (10 s, 12-lead) ECG recordings

Dearth of clinically useful diagnostics limits growth of personalized medicine

Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis

Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis

China patent law and implications for international pharmaceutical companies

Challenges in the treatment of hypertriglyceridemia: glass half empty or half full?

Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency

Carbamazepine adverse drug reactions

Cangrelor in percutaneous coronary intervention

SHOW MORE ARTICLES

Building a better understanding of the burden of disease in familial chylomicronemia syndrome

2nd International China BioPharmaceutical Symposium

Assessing the adverse effects of antimuscarinic drugs in older patients: which way forward?

Antibiotic resistance: the challenge from an industry perspective

Anti-inflammatory drugs as moderators of antidepressant effects, especially those of the selective serotonin-reuptake inhibitor class

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits

Adverse drug reactions to osteoporosis treatments

Advances in the generation of mouse models to elucidate the pathways of drug metabolism in rodents and man

A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone

A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone

A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidone

A resurging boom in new drugs for epilepsy and brain disorders

FAQs

Expert Review of Clinical Pharmacology has an SJR of 1,072 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2480 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Expert Review of Clinical Pharmacology is 31%.

Expert Review of Clinical Pharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Expert Review of Clinical Pharmacology?

What is the APC / publication cost?

What is the acceptance rate?